Across TCGA pan-cancer cohorts, TGIF2P1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of TGIF2P1’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where TGIF2P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TGIF2P1 is over-expressed in tumor, although a few such as THCA and LUAD show the opposite, repressed pattern.
HNSC, CHOL, and THCA are the cancer types where TGIF2P1 tumor–normal differential expression is most reproducible.